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INTRODUCTION

0'Shaughnessy1 first suggested the treatment of patients with intravenous
fluids in the early 1800's. Subsequently, Dr. s Latta2 and Weatheri113 and others
treated patients by administering solutions of selected salts intravenously . Until the 1920's, hospitals depended exclusively upon solutions prepared in their
own laboratories. Techniques allowing large volume commercial production
were not developed until the late 1920's and in 1929 Dr. Don Baxter (Don Baxter ,
Inc.) began providi.ng commercial intravenous fluids in the Los Angeles, California, area and nationwide in late 1931. 4
A greater awareness is now recognized for the complexities of intravenous
fluid production, not just from the standpoint of sterility but for pyrogenicity,
formulation and administration. Basically, the formulae and methods of administration today are little different from the earlier hospital produced fluids.
The delivery system of the intravenous fluid has traditionally been the
rigid glass bottle with some device to allow air venting.

The venting allows

equalization of air pressure by permitting ambient air to enter the bottle. This
has been accomplished in one of two ways.

First, a ball-check valve (many

early systems used a "butter-fly" device) t hat permitted the ambient ai r to
enter the bottl e and pass through the fluid . Usually the devices provided some
type of gross filtration of the air, but by no means was sterilization achieved .
Second, a vent tube running the length of the bottle and directing ambient air

into the bottle over the surface of the fluid.

It should be noted that in each

case the non-stel"ile ambient air comes into intimate contact with the intl"avenous fluid.

The delivery sjrstem as a unit represents an open pathway into

the patients' veins and the non-sterile ambient air is a potential vehicle for introducing Ol"ganisms into this pathway.
There was no alte-rnative available if the physician wanted to administer
intravenous fluids to his patient. Any system used relied upon non-stel"ile ambient air in order to function;

liowevel" a new intravenous fluid administration

system is now available in the United States. 'I'l"avenol Laboratories has now
marketed intravenous fluids in a flexible plastic bag (ViaflexR) that does not
rely on entry of ambient air to function.

The plastic bag simply collapses to

allow the fluid to vacate the container.
The official literature disseminated by 'I'l"avenol Laboratol"ies refers to
the ViaflexR system as
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an innovation in parenteral packaging. n Advantages

sited for this system are: reduced weight, reduced bulk, freedom from breakage as a result of cal"eless handling or exposure to freezing.

However, a patient

would benefit only indirectly fl"om these advantages. A mol"e impol"tant considel"ation fo ... the patient is safety. Does this 11 innovation in parentel"al packaging" subject the patient to less risk of septicemia resulting from a contaminated intravenous fluid administration system?
Microbial contamination of an intravenous fluid may occur in many ways,
but among these, three are foremost.

l.

During manufacture of the fluid and components

2.

In preparation of the delivery system prior to administration

3. During actual administration of the fluid to the patient
By utilizing recognized good manufacturing practices plus adequate controls, the manufacturer is able to virtually eliminate the first source of contamination.

During the course of this study, background data was collected to

verify this observation.
Contamination occurring during assembly of the system and that encountered during actual administration becomes more difficult to eliminate.

The

propensity for contamination during assembly of the system is determined by
the design of the system and the technique utilized by the individual preparing
t he system.

A poorly engineered delivery system or one with serious design

deficiencies would require meticulous technique from the individual. Such a
system would be constantly challenged and subject the patient to an undue risk.
Contamination arising during the administration of the fluids would be determined by the basic design of the system and its dependence on environmental
factors.
The intent of this study was to methodically explore microbial contamination of a traditional glass bottle system and the newer flexible plastic bag
system simultaneously.

Utilizing nurses in a patient care area and pharma-

cists in a central additive service configuration each system was subjected to
conditions approximating actual situations.

The frequency of microbial growth

in either system was used to serve as a comparison between the two systems.

REVIEW 0 F THE LITERATURE

For many years authors have been expressing fears of airborne microbial
contamination. Wells and Wells5 accurately stated the problem although, in a
somewhat flowery ,manner; "In the dissemination of plant life, the atmosphere
is nature 1 s prime sower of the seed and thus vitally affects all living things. "
The suggestion that common air supplies be rendered free of microbial contamination, while impractical on the scale outlined by Wells and Wells6, is precisely
what is being attempted today on a limited basis in laminar air flow hoods and
in clean rooms.

Elaborate filtration devices are not the only means of ach iev-

ing an atmosphere with fewer bacteria.

By the use of sterile dust-free surgical

gowns, Duguid and Wallace7 showed that one source of bacterial contamination,
i.e. dust-borne bacteria, could be drastically reduced.

The study conducted by

Cole and BernardS indicated that careful housekeeping techniques could be expected to reduce the contamination level. Other workers have found that very
basic matters such as the number of personnel in a given area and the extent of
physical activity also played key roles in the levels of air-borne microbial contamination encountered. 9 Ford, Petersen, and MitchelllO came to the same
conclusions and suggested the control of traffic in the operating rooms to reduce
the level of air-borne microbial contamination.
The role of technique and the person preparing the intravenous fluids for
administration in contributing to microbial contamination of the intravenous

fluids was s hown by the work of Love.ll This study indicated that imprope,.
assembly of the intt·avenous fluid administ,.ation system was an important factor
in the rate of microbial contamination resulting.
In examining a series of actual in use intravenous fluids, Deeb and Natsios12 attempted to provide a value for the frequency of microbial contamination.
Their study showed that the patient receiving intravenous fluids must be considered a being at risk. '

Hermanl3 endeavored to provide the pl"acticing pharma-

cist with an appreciation of the role he may play in contributing to microbial
contamination by pointing out that healthy hospital workers may carry recognized
pathogens. This point was corrOborated by the work of Williamsl4 showing that
transient carriage of Staphylococcus aureus by healthy individuals could be harmful
to patients.
The prominent epidemic of septicemias arising from the use of contaminated intravenous fluids , first documented by Duma, Warner and Daltonl5 is
an example of contamination occu,.ring at the point of manufacture. The extent
and possible underlying source of the contamination was subsequently noted by
the Center for Disease Controt.l6 Reports are still appearing in the literature
documenting specific casesl7 and various methodologies employed in other outbreaks studied.l8
The report of Rupp and Fornil9 documents a previously unregognized means
of contamination of an intravenous fluid, that of actual entry of an insect into
the container via the vent tube.

The potential of this means of contamination

was suggested in an editorial from England20 pointing out that these insects may
be carrie"t"S of pathogenic microorganisms . This break in the integrity of the
system was directly related to the basic design of the administration container.

Henry and Harrison 21 warned of the potential for contamination resulting
from the improper use of volume control sets in administering intravenous
fluids; a warning also voiced by Duma, Warner, and Dalton. 15
The literature abounds with articles describing septicemias resulting from
in-dwelling intravenous catheters. 22 - 33 Other reports appear in which intravenous fluid therapy is indicted as the most frequent source of infection3 4 or
evidence strongly suggests the fluid as the source of contamination. 35
The gentle flow of air into the vacating fluid container does not alone represent the means of introducing the microbial contaminants into the fluid . Michaels
and Ruebner 36 detected bacterial growth in intravenous fluids during administration and concluded the contamination occurred "either while the bottles were
being changed or by contaminated air sucked into one of the bottles through the
air-replacement tube." It was subsequently shown experimentally by Perceva1 37
that the inrush of ambient air upon opening the fluid bottle with a partial vacuum
could be the vehicle for introducing organisms into the intravenous fluid.

Con-

current environmental air sampling was used by Perceval to serve as a comparison of the risk factor.

Perceval found that the degree of environmental contamina-

tion did affect the rate of fluid contamination. 0 1 Hare, Shapiro and Creeden38
concluded that air microbial contamination has to reach a certain level to become
clinically significant, although that level was not defined.
In the study conducted by Arnold and Hepler, 39 the contamination rate of
fluids opened in various areas of their hospital ranged from zero to nearly 10%.
The overall contamination rate was approximately 5% and in their opinion raised
serious queStions regarding the safety of intravenous fluids being opened in a

contaminated environment.

A subsequent study by Hansen 40 at the same institu-

tion concluded that an open or air-dependent system was more likely to become
contaminated through the entry of non-sterile air when the partial vacuum was
released . Hansen further suggests these air-dependent systems be opened only
in a l aminar air flow hood to minimize the contamination potential.
Clearly, the literature shows that a great many people have been concerned
for a number of years with the potential for infections in the hospital environment.
This concern has included the administration of intravenous fluids and any source
that may be contributary, L e. manufacture, assembly of the unit and administration.

DESCRIPTION 0 F THE STUDY

The study in question was designed to examine a new intravenous fluid
delivery system from the standpoint of microbial contamination.

To serve

as the base -line, a traditional delivery system was subjected to identical procedures concurrently with the new system.
The major differences between the two systems being studied was the fluid
containe-r.

The traditional container consisted of the glas s bottle with a vent

tube running the length of the bottle.

The new system was a flexible plastic

bag that did not require the entry of ambient air for evacuation.
In recognition of the alternatives that exist with regard to intravenous fluid
preparation, both nurses and pha,.macists were utilized in the study.

Obviously,

vastly different conditions existed in the areas used by the study personnel for
actual preparation of the fluids.

The pharmacists used a certified l aminar air

flow hood and the recognized procedures of the Medical College of Virginia
Hospital Pharmacy of a lint-free gown, surgical mask and cap.

The procedure

also included a scrub using a sterile 3o/c hexachlorophene sponge and cleansing
of the hood and all materials placed inside the hood with a solution of 70% isopropyl alcohol.

The nurses prepared their fluids in a medication room, unal -

tered from the normal setting with regard to traffic, housekeeping, ventilation,
and distractions.

The particular nurses were carefully chosen to find ones having had no prior
experience with the new system and no prior instruction in the recommended procedures.

Likewise the pharmacists had no instructions in handling the new system

but they were somewhat familiar with the flexible plastic bag.
Each nurse and pharmacist then proceeded to prepare one liter of an intravenous fluid containing one additive and attached an administration set and a final
filter distal to the administration set.

At the nursing unit (the same medication

room) the nurses then attached a needle and proceeded to run the intravenous fluid
into a sterile evacuated collection bottle. (Figure 1)
When the fluids had almost emptied, they were clamped with the device provided by the manufacturer and allowed to stand at room temperature for approximately 24 hours undisturbed.
The fluids were next collected by study personnel and delivered to the laboratory for sampling.

After collecting the necessary samples, the materials were

delivered to the laboratory for incubation and speciation.
To provide a positive concurrent control on both sampling technique and microbiology detection methods, small quantities of Escherichia co li (ATCC 11 229) were
added to one bottle and one bag of fluids of each one -day run.

The addition of the

microorganism was performed by the nurse or pharmacist preparing the fluids
and the unit contaminated was unknown to both the persons performing the sam pling and those in the microbiology laboratory.
Specifically the study was to proceed in the following fashion:
Phase One:

collection of laboratory background data of individual
components, by the study personnel.

lO

Phase Two:

preparation of the intravenous fluid systems by nurses

on a patient care unit.
Phase Three: preparation of the intravenous fluid systems in a laminar
air flow hood by pharmacists, using the prevailing standards of the department.

ll

MATERIALS AND METHODS

MATERIALS

The intravenous fluids and administration sets utilized were manufactured
by Baxter-Travenol Laboratories , Inc. (Morton Grove, Til.

60053).

The in-

travenous fluid selected was 5% Dextrose in Lactated Ringer s packaged in one
1

liter quantities in the traditional glass bottle (catalog number 2A2074) and the
ViaflexR flexible pl astic bag (catalog number 2B2074) . The administration
set was the PlexitronR R-42 set (catalog number 2C0005). The additive selected to be included in each unit was 0. 9% Sodium Chloride without a preservative, packaged in 30 ml sin gle dose vials, manufactured by Baxter-Travenol
Labo r at ories, Inc. (catalog number 2D4543).

All supp1ies were purchased on

the open market through normal distribution channels.
Millipore Corporation (BediDrd, Mass.) manufactured the Swinnex-25R
0. 45p in-line final filter (catalog number SX HA0250S) used throughout the study.
Empty Vacuum Plasma collection bottles were used to collect the filtered intravenous flui ds and were manu factured by Baxter- Travenol Laboratories, Inc.
(catalog number 2A8504).
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METHODS
All bacteriological manipulations were performed in a l aminar air flow

hood (Abbott Cl ean Air Center, Bench Model BK No.l024) by the same two individuals, a phys ician and a pharmacist.

The l aminar air flow hood itself

was certified during the course of the study (November 3, 1971, and June 29,
1972) by Contamination Control Labs

(located in Livonia, Michigan).

Prior

to use the laminar air flow hood was prepared by allowing to run for at least

one hour and swabbing the inside surfaces (top, sides and work area) with
70% isopropyl a lcohol.

Before beginning any sampling procedures, blood

agar settling plates were pl aced on either side of the work area and fastened
to the sides (approximately 8- 12 inches from the outside edge) at a 450 angle

to interdict the flow of filtered air.

The settling plates we-re left in place

until the sampling procedures had been completed; the last activity to be removal
of the blood agar settling plates, secure the top in pl ace, and deliver the exposed pl ates to the bacteriology laboratories for incubation and identification.
Incubation was for seven days at 37oc , being checked daily for growth.

Phase One: Background Data Coll ection
Background data was coll ected to prove the sterility of all individual com{X>nents and to provide a check on the technique of those performing the s ampling.
In this phase of the study, fifty (50) one liter gl ass bottl es of 5% Dextrose in
Lactated Ringer's, fifty (50) one liter flexible plastic bags of 5% Dextrose in
Lactated Ringer 's, forty (40) int ravenous infusion sets , and fifty-four (54) final
in-line filters were sampled. Actual sampling was performed in the following
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mannet' for the glass bottles.

First , the metal ring and metal disc weT"e removed

outside of the laminar air flow hood. Next the surface of the latex covering was
dried with sterile gauze and the surface then flamed.

The intravenous fluid bot-

tle was then placed in the laminar air flow hood in a horizontal configuration with
the vent tube in th e lower position.

The vacuum was next released by inserting

a sterilized air filter through the hole provided for the infusion set.

(The ste-

rilized air filter was prepared by removing the plunger of a five cc syringe and
placing a plug of cotton in the barT"el and attaching a one and one-half inch twenty
guage needle ; the entire unit was wrapped and sterilized.) Ten ml of the intravenous fluid was removed with a sy,.inge through the vent tube of the bottle.
opening of a bottle containing eighty m l of fluid thioglycollate

tre

dia was next

flamed and the ten ml of intravenous fluid then aseptically added.
of the bottle was again fl amed and the top replaced.

The

The opening

The contents of the bottle

were then incubated at 37°C for seven days and any resulting growth speciated.

The flexible plastic bags were next sampled using a similar procedure with
a few exceptions.

After removing the intravenous fluid in the plastic bag from

the outer plastic wrap , an Oschner clamp was used to support the medication port
and the latex surface flamed. Since no procedures were required to equalize
p't'essure as seen with the traditional glass bottle, the lO ml sample of the fluid was
next withdrawn. Addition of the sample to the bottle containing fluid thioglycollate
media was performed in an identical manner to that described for the glass bottle.
In order to subject the intravenous infusion sets to the same sterility and
procedural checks performed on other components of the study, fluid thioglycollate
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media was flushed through each set. A rubber-stoppered container of fluid
thioglycollate media was flamed, swabbed with a sterile alcohol swab, and
20 ml of media withdrawn by a needle and syringe in the laminar air flow hood.
After passing the media through the length of the intravenous infusion set, it
was collected in a sterile screwcapped test tube.

The opening of the screw-

capped test tube was flamed before and after addition of the media.
The final-in-line filters were removed from the manufacturers package
and a sterile intravenous infusion set and 20 guage 11/2" needle attached.

The

complete unit, filter, needle and set, was then allowed to stand for 24 hours
in the same medication room to be used by the nurses in the study in their
assembly of bottles and bags of fluids.

At the end of this incubation period,

the filter, needle, and infusion set units were transported to the hospital pharmacy for sampling.

The unit was dis-assembled in the laminar air flow hood

and the filter case opened, the filter membrane and gasket removed using
flamed forceps and placed top down on a blood agar plate for one to two hours.
In the microbiology laboratory, the filter membrane and gasket were removed
and placed in a test tube containing fluid thioglycollate media.

Both media were

then incubated as other media used in the study and any resulting growth noted.

Phase 'l\vo: Preparation by Nurses on a Patient Care Unit
Fifty-five (55) glass bottles and fifty-five (55) flexible plastic bags were
sampled in addition to the control solutions by registered nurses accustomed
to handling intravenous fluids.

In this phase of the study, all supplies required

by the nurses to prepare the intravenous fluids were delivered to the unit and
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the nurses left alone to prepare them without intimate supervision.

While the

study personnel were available (by either paging or telephone) for any problems
that may be encountered, they were not physically on the unit during the manipu lations.

The nurses were allowed to read any literature that accompanied the

fluid but no additional instructions were forthcoming.

The intravenous fluids

were to be prepared as for any patient except (l) the additive to be used was
0. 9% Sodium Chloride (2) a final in-line filter was to be used (3) instead of
inserting the needle into the patient's vein , the fluid was allowed to run into
the empty vacuum bottles supplied.
The additives were prepared in the following manner.

The nurse, using

a 20 ml syringe, withdrew 20 ml of the 0. 9% Sodium Chloride without a preservative from the 30 ml single dose vial.

Ten ml of the additive was injected into

the intravenous fluid container and the remaining 10 ml in the syringe l eft for the
study personnel. The following day when the completed fluids were retrieved,
the 10 ml of additive in the syringe was transported to the pharmacy with all
other supplies, and in a laminar air flow hood injected into a bottle containing
80 m l of fluid thioglycollate media and incubated at 37°C for seven days.

This

procedure provided a method of checking each additive for sterility and therefore,
subjected the system to another check of its integrity.
After the nurse completed the assembly of the system, she regulated the
flow rate to allow one liter to be emptied in approximately two hours.

Before

the entire liter was emptied, the nurse was requested to stop the flow leaving
50-100 ml of fluid remaining in the container . The entire unit was then allowed
to stand until the following day (18-24 hours) undisturbed , on the nursing unit
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Next, the study personnel picked up all of the units and transported them intact
to the hospital pharmacy for sampling.

In transportation the units were carried

along the same pathway a patient would follow if movement were required.
In the laminar air flow hood the samples were collected as follows.

The

fi rst 10 ml of the remaining intravenous fluid to pass through the needle s till attached to the final fil ter and set was collected in a bottle containing 80 ml of fluid
thioglycollate media. The top of the screw-capped bottl e was fl amed before and
after the sample was added.

The remainder of the intravenous fluid was allowed

to run through the intact set and filter , the last 5 to 10 ml being Collected in an

empty sterile screw-capped test tube.

The test tube top was flamed before and after

addition of the sample . Next the final in-line filter was removed fr om the set-up.
The unit was disassembled and using flamed fo rceps , the gasket and the filte r
membrane aseptically removed in the laminar a ir flow hood to a blood agar plate;
top s ide of each facing the media s ur face.
The lO ml sample of the additive in the syringe was added to the media in a
manner previously described.
The samples were then trans ported to the microbiology laboratory an d the
same technician performed the following actions. The two bottles containing
the fluid thioglycollate media (the firs t 10 ml o f flu id drawn from the set-up after
overnight on the ward and the 10 ml additive control ) were pl aced in the incubator
at 37°C.

From the test tube containing the l ast fluid to pass through the set and

filte r, a 0 . 5 ml sample was removed and s tre aked on a blood agar plate. Next
another 0 . 5 ml sample was r emoved and streaked on an EMB plate (eosin methylene
blue).

Finally, 1 ml was removed to a sterile petri dish and a pour plate pr epared
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using Soybean Casein Digest Agar. All three of these samples were also incubated at 37oc.
The blood aga.,. plates containing the gasket and filte,. memb.-ane we .... e opened
and each .,.emoved to a separate test tube containing fluid thioglycollate media.
The th.,.ee samples were likewise incubated at 37oc.

Each day the incubat-

ing samples were che cked and any resulting growth speciated.

Incubation and

daily checking of the samples con tinued fo r seven days.

Phase ThT'ee: Prepa... ation of the Intravenous Fluids in a Laminar Ai-r Flow Hood
by Pharmacists
In this phase of the s tudy, a phar·macist accustomed to handling intr·avenous
fluids p,.epal'ed the set-up as would be expected in a cenb·al additive service.
The phar m acists p.,.epa,.ed a total of fifty-five (55) glass bottles and fifty-fou.,.
(54) flexible plastic bags containing the int.,.avenous fluid s.
we.,.e p.,.o vided to the pha-rmacist as noted in phase two.

The same supplies

Each pha-rmacist fol-

lowed the usual pha-rmacy p-rocedu.,.e fo.,. p.,.epa.,.ing int-ravenous fluids which ineluded a hand sc-rub us ing a ste-rile 3% hexachlo.,.ophene sc.,.ub sponge (catalog
numbe.,. 3000, Pha.,.maseal Labo.,.ato.,.ie s) , and wearing a lint-f.,.ee cap and gown ,
and a su.,.gical mask.

The fluids we ... e p...e pa.,.ed in a simila-r manne.,. to phase two,

with .,.ega..-d to the additive utilized.

The 10 ml .,.emaining in the sy.,.inge again

se-rved as the cont...ol fo.,. the additive.

The pha.,.macist also inse.,.ted the fluid

administ-ration set and attached the final in-line fil te.,..

Since the fluids p.,.epa..-ed

in the glass bottle had an open vent tube, some means of plugging the vent tube
fo.,. transit had to be devised.

A ste ...ile plastic device was aseptically inse..-ted

into the vent tube by the pha..-macist to fulfill this pu.,.pose.

The assembled unit

18

was transported to the nursing station by pharmacy personnel and left for her to
11

administer".

The nurse then attached the appropriate needle, where indicated

withdrew the sterile vent tube plug
lection bottl e provided.

devic~

and ran the fluids into the empty col-

Regulation of the flow rate, retrieval by study personnel,

sampling procedur es and microbiology methods were identical to phase two.

T he

same room and conditions were also used for the nurses 1 portion of the exper iment.
In both phase two and phase three, the nurse or pharmacist selected one bottle and one plastic bag and deliberately contaminated that unit with a solution containing Escherichia coli.

The identity of the contaminated unit was unknown to the

personnel per forming the sampling and microbiological techniques.
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RESULTS

Phase One: Background Data (Table l)
The fifty (50) one liter plastic bags of 5% Dextrose in Lactated Ringer 1s
did not exhibit any evidence of contamination by the study methodology employed.
However, a like number of one liter glass bottles of the same fluid resulted in
one bottle yielding a positive culture for a Penicillium species . Th is represents a rate of contamination of

2%. No pos iti ve cultures resulted from forty

(40) intravenous infusion sets sampled.

The fifty -four (54) final in-line filters

sampl ed produced two positive cultures for a rate of 3. 7%.

The organisms

isolated from the filters were a Staphylococcus epidermidis and a Flavobacterium
species.
Blood agar settling plates placed in the laminar air flow hood during all of
these sampling procedures yielded a Bacillus species, a Staphylococcus epider~.

a Mycelium sterilia, a Penicillium species and an Aspergillus species.

Phase Two: Preparation By Nurses on a Patient Care Unit (Tables 2 &. 3)
Three general duty registered nurses prepared a total of fifty-five (55) liters
of intravenous fluids in the glass bottle and fifty-five (55) liters in the plastic bag.
Of the fifty-five (55) glass bottles, four bottles were positive; a rate of 7 . 1%.
The organisms isolated were a Bacillus species, a Streptococcus species and
a Staphylococcus epidermidis.

The same number of fluids in the plastic bag
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produced six pos itive cultures or a rate of 10 . 9%. Here the organi sms were
a Bacillus speci es , a Micrococcus spec ies, and a Staphylococcus epidermidis.
Settling plates of blood agar in the laminar air flow hood concurrent with t he
sampling procedures revealed a Staphylococcus epidermidis , a Bac illus s pec ie s ,
and a Micrococcus species.

Blood agar settling plates pl aced in the same room

during nurse preparation yi el ded an Aspergillus species, a Staphylococcus au reus,
a Staphylococcus epidermidis, a Micrococcus species, a Streptococcus s pecies,
and a Bacillus species. With the fluid s in glass bottles, one nurse (C)

accounted

for all four of the contaminated fluids detected . However, when utilizing the
fluids in plastic bags , this same nurse had no fluids contaminated although t he
other two nurses (A and B ) each contr ibuted three contaminated fluids to the
total of s ix detected .

P hase Three: Pharmacist Preparation in a Laminar Air Flow Hood (Tables 4 & 5)
The two pharmaci sts prepared fifty-five (55) liters of fluids in glass bottles
and fifty -four (54) liters in plastic bags.

Three glass bottles were found pos it ive

for a contamination rate of 5. 4%. The organi sms isol ated were a Staphylococcus
epidermidis, a Micrococcus s pecies , and a Bacillus species. The fifty -four (54)
liters in the plastic bag produced three positive cultures; a contam ination rate of
5. 5%. With the plastic bags the organisms were an Escherichia coli , a Bacillus
spec ies and a Staphylococcus aureus.
The blood agar settling plates from the l aminar air fl ow hood during sampling
yi elded

a~

~

Pharmacist B contributed two contaminated fluids to pharmacist A's

species, a Mic rococcus species, and a St aphylococcus ep ider-
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one contaminated fluid fo .... both the glass bottle and pl astic bag se-..ies but in each
instance, B p.,.epa... ed a

~eate ....

numbe.- of fluids than did A.

Subsequent discussions with the pha.,.macist involved -..evealed that the plastic
bag that became contaminated with the Esche.,.ichia coli was p,.epa.,.ed immediately
afte.,. pu.... posely contaminating a glass bottle with the cont.,.ol o.,.ganism, an Esche-

....ichia coli.

The mic..-obiology labo... ato-..y subjected both cultu,..es to fu ...the.,. testing

and fom1d each to give the same fe..-mentation patte-..ns with those suga... .,.eactions
known to be va.,.iable in the genus Esche...ichia; p-..esumpti ve evidence that the o ...ganism emanated f.,.om same sou-rce as the control o ...ganism.
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STATISTICAL ANALYSIS

The .,..esults of the study we.,..e subjected to statistical analysis by Fishers 1
Exact Test and the Chi SquaT'e Test.
The data indicate the contamination .,.ate fo,. nurse p,.epa,.ation of the
plastic bags was significantly

~eater

than the backwound when examined at

the 5% level. (Table 6).

When small sample sizes a-re utilized, such as this study, .,.ates of less
than 50% occur,.ence will tend to be undeT'estimated mo,.e often than ove,.estimated.

The example stated by Schor41 provides a graphic demonstration of

this tendency.

Assuming a prevalence rate of 5% fo,.. an occu,. ... ence, and using

ve-ry small sample sizes of five, 774 samples out of every 1000 will yield a O%
p-revalence T"ate (an underestimate) and only 226 out of 1000 on the ave,.age
will yield ,.ates ove,.. 5% (an overestimate).

TheT'efol"e, a lal"gel" sample size

would be l"equil"ed to ovel"COme this tendency.
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DISCUSSION

As stated by Dudrick42 "The intravenous route is generally recognized as
the most definite and practical means of systemic administration of medication
and rapid or massive infusion of electrolytes and fluids.

11

This statement accu-

rately justifies the need for a means of adm inistering intravenous fluids in a
practical and efficient manner.

However, the patient should be afforded the

benefits of this valuable therapeutic tool without being subjected to any unnec-

cessary risk.
While the incident reiX'lrted by Rupp and Forn_il9 i s probably an isolated
occurrence, the undesirable nature of an air-dependent administration system
cannot be denied.

By utilizing a non-air dependent system, e. g. ViaflexR,

the potential indicated by Perceva1, 37 Arnol d and Hepler, 39 and Hansen40
could be eliminated, although the clinical significance of the open airway has
not been demonstrated.

More concern must be shown for the mode of admin-

istering intravenous fluids, but at the same time, any new approach must
undergo careful scrutiny.
In conducting a study of this nature, sel ection of the personnel is a vital
factor.

The operation of a centralized additive service, the configuration se-

lected for the pharmacists participation in this shtdy, requ ires that the personnel
be familiar with the rudiments of aseptic technique and possess the ability to
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perfOTm these tasks without contaminating the system being utilized.

It would

be anticipated that personnel in this a,.ea would be somewhat familiar with the
tasks to be performed, although likely of diffe.,..ent degy-ees of pl"Qficiency.
Therefore, the pharmacists selected fo.,. the study were experienced in an additive operation, exhibited a high level of pT'oficiency and an above average awa... eness for contamination potential. In rega'"d to the selection of nu"'sing personnel
for the study, it was felt that to utilize only those nurses thoroughly schooled and
familiar with the new syftem would be somewhat tmrealistic.

The intewtty of the

delivery system must be examined in the light of the inevitable staff turnover of
of nursing and the necessary time lag in t-raining new personnel.
nu~ses

proficient and

spu~ious ~esults

in the

no~mal

expe~ienced

and imply a

in a new

lowe~

delive~y

contamination

~ate

nurse population. In choosing nurses

To include only

system would tend to p-..oduce
than would be

unfamilia~

encounte~ed

with the

non-ai~

dependent delivery system, the system was essentially being challenged to dete~mine

its limitations in the face

ofimp~ope~

technique.

However, to moT'e

fully answer this question of improper technique would require training of these
same nurses, allowing them to become proficient and then

~epeating

this phase of

the study.

The phaT'macists did pe.,..form one task that is not considered to be routine
in many centralized additive p.,..ograms . Each intravenous fluid p.,..epared by the
pharmacists had the administration set attached in the lamina,.
along with the final in-line filte,..

nu.,.sing station the nurse had only to attach the needle to the
into the vacuum containeT'.

ai~

flow hood,

As a -..esult, when the nnits a.,..,..ived at the
filte~

and inse,.t
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In viewing the data one must appreciate the conditions that are identical
and those dissimilar.

The nurse assembly of the unit, including needle attach-

ment to pha,.macy p.,.epa... ed fluids, was affected in an a.,.ea no,.mally utilized
fo.,. this pu,.pose.

The medication ..-oom had its normal t>·affic, no attempt being

made to alte... the envi.-onment. On the othe"' hand, pharmacist assembly used an
a ... ea free f...am excessive t>-affic, in a ..-oom with the air w-ossly filtel"ed and the
actual prepa-ration in a laminar air flow hood. One condition standard to fluids
prepared in both a-reas was the wa,.d environment in which the fluids were r\Ul
and allowed to incubate ove"'night.

He.,..e again, no attempt was made to alter

the conditions from those no,.mally encounte,.ed.
The value of positive concu.,.,.ent controls cannot be undel'est:i.mated. It
would be most difficult to assess the findings of a study of microbial contamination in the absence of data to define the sensitivity of the procedures. Obviously,
one must be able to retrieve organisms added as controls with a
bility and sensitivity that produces a valid finding.

de~ee

of relia-

For this pu,.pose one unit of

each system was innoculated with a knov.rn concentration of Esche.,.ichia coli fo,.
each se.,.ies ...un. Although the rnic.,.oo ... ganisms were added on a blind basis, the
contaminated unit being known only to the nu,.se o.,. pha.,.macist p.,.epa.,.ing the
fluid, the cont--01 solution was identified in each instance .
The concent.,.ation of the control solution of Escherichia coli .,.anged f,.om
113 Colony Fo.,.ming Units pe,. 10 ml to 230 Colony. Fo,.ming Units pe ... lo ml with
an ave ... age concent.,.ation of 171 Colony Fo,.ming units per 10 ml.

No attempt was

made to quantitate the Escherichia coli recove ... ed f,.om the control solutions.
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Based on the concentrations of the contT-ol solutions added to the one lite"" conta:ilers, the lowe-.. limits of detection would appea... to be less than one colony forming
unit peT' millilite,..

Howeve,., the ideal detection capability should be one colony

forming unit in the entire container, since a solution with one micl'Oo.,.ganism is

contaminated.
Chance obse,.vation .,.evealed that mic...oo,.ganisms f.-om the control fluids
were not found in the filtrate, i. e . the fluid collected afte,.. passing thT"ough the
final filter , except in one incident when the filte"" memb... ane was found to be
.-uptured when opened. This finding would appea-.. to a~ee with othe.,.s43 indicating that the final filte ... effectively •·emoves most bacteda from the fluid being administeT"ed.

When one begins to examine the mic,.oo,.ganisms encormte...ed in any wo.,.k
of this natu.,.e, the immediate t endency of the neophyte is to classify the o-..ganis m s by p athogenicity, i.e. pathogenic o,. non-pathogenic. In ,.eality, howeve,. ,
the potential fo-.. pathogenicity must include the o,.ganisms that constitute the
body flo-..a and may s ubsequently cause an oppo-..ttmistic infection. 44 Dalton and
Allison 45 s howed that Staphylococcus e pide,.midis , usually conside,.ed non-pathogenic, was the causative agent in a significant pe,.centage of bacte,.emias in thei,..
hospital. Although u s ually conside-..ed to be contaminants, the p-..esence of m ic,.oo ..ganisms s uch as Staphylococcus epide,.midis must be viewed with conce,.n
since bacte...ial endoca.-ditis ...esulting f-rom this agent cannot be conside.-ed a
...a•·ity · 4 5 Some wo ...ke...s have suggested that these facultatively pathogenic o ... gantsms may be an inte...mediate g""'up between the ...eally non-pathogenic st--ains
and documented p athogenic st--ains of staphylococci. 46 In any event the p ...esence
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of m ic,.oo ... ganisms in intravenous fluids must be conside,.ed potentially ha ... mful
... egardless of the origin of contamination .
The mic.,..oorgani sms encounte..-ed in this study appea,.ed to be frOm touch
contamination. The significance of ai.,.-bo .... ne contamination was not s hown .
Those mic.-oo.,.ganisms found in the collection of backg.-ound data could easily
be attributed to technique, but never-the-less , at a level acceptable to the
s tudy pe,.sonnel and pe... mitting advancement to the s ubsequent phases.
It is interesting to note that nead y on e- fouT'th of the gl ass bottles pT'e-

pa,.ed by one nurse we""e contaminated, the othe,. two nur ses having no bottles
contaminated (Table 2). However , thi s same nu,..se , when utili zing the pl astic
bag had none contaminated while the othe ... two nul"ses h ad appl"oximately one sixth of each of thei"s contaminated (Table 3). The explanation fo" thi s finding
was not appa"ent.
When the pha"macists P"epa"ed the fluids in a Htmina" ai" flow hood,
the findings we"e the same fo" both gl ass bottles an d plastic bags, no diffe"ence
in eithe" the ,.ate of contamination o" the individual pl'"epa"ing the fluid (Tables
4 & 5) . The occu""ence of the one plastic bag with Esche"ichia coli contami nation was the cause of conside"able con ce"n . While it appea"ed the Esche"ichi a
~was

the same s train as used fo" control pul'"poses, this contamin ation in the

hands o f a most capabl e pha"macist shows that the l amina" ai" flow hood alone
does not assu"e ste"ility of admixtu"es.

Meticulous ca"e must be exe"cised

by the pe..-sonnel at all times even in the l amina" ai" flow hood.

The standa"d

p-rocedul'"es e mployed by the pha"macists in this s tudy, i.e. a disposable lint-fl'"ee
&own with el astici zed wdst bands, a s ul'"gical mask and cap an d the SCl'"ub procedu"e
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with sterile 3% hexachloT'Ophene should be considered the minimum acceptable
standard.

Cleansing of all products placed in the hood with 70% isopropyl al-

cohol reduces pa.,.ticulate matter and keeps the micT'Obial contamination to a
minimum, both of vital concern to the practicing pha"'macist.
The blood aga.,. settling plates placed in the laminar air flow hood
during each sampling procedure further indicates that the environment inside
the hood is fa.,. from steT'ile (Tables 1-5). DuT"ing the sampling procedures,
study personnel wo-re surgical masks and sterile gloves while wo"'king in the

laminar ail" flow hood and did not WOT'k betw-een the filte,.. and the blood agar
settling plates.
The individual preparing admixtures must not undertake this task
with a cavalieT' attitude on the false assumption the laminar air flow hood will
cover up his shortcomings.
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CONCLUSIONS & RECOMMENDATiONS

The following points can be concluded from this study:
1. Using pe r sonnel with no training in the proper use of the flexible plastic
bag, no s ignificant difference in the contamin ation rate could be seen
when compared to the traditional glass bottle.
2. A non- air- dependent intravenous fluid administration system should prove

safer for the patient in that non-sterile ambient air cbes not enter the container and come into intimate contact with the fluid .

3. Based on the organisms detected, the data show that touch contamination
is the major source of contamination in the intravenous fluid delivery
systems tested.

4. A central intravenous fluid additive service c an be expected to ,.educe the
level o f contamination encountered in the fluids if the proper technique i s
employed .
5. A la min ar air flow hood alon e is not s uffic ient to insure sterile intravenous
flui ds . Hos pital pharmacists s hould utilize the laminar air flow hood coupl ed with a greate"t" awareness of the technique required to provide a sterile
product.
6. The laminar air flow hood does have limitation s and s hould not be challenged
by the operator , his l ack. of proper a ttire, and i mproper technique .
7 · Ail·borne contamination was not shown to be a majo,. facto,. in overall contamination of intravenous fluids.
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The intravenous fluid delivery system should be designed to require a
minimum of manipulations to administer to the patient since touch contamination appears to play a major role in contamination.
The introduction of the non- air-dependent intravenous fluid delivery system is the first s tep in closing the entire intravenous administration system
to entry of microorganisms.

The airborne contam ination, although of undocu-

mented clinical significance, has been eliminated by the flexible pl astic bag.
The next area that should be attacked by first the pharmacist and then industry
is the problem of touch contamination. The individual pharmacist in the hospital may take action by attaching the administration set in the environment of
the laminar air flow hood, thereby • preventing ex)Xlsure of the system to an
uncontrolled situation. Next industry may take the initiative by providing an
intravenous fluid administration system of proven sterility by manufacture of
the contai ner and administration set as an integral unit, eliminating manipulations at the patient bedside, the medication room, or even the laminar air flow
l10od. Admittedly, this approach would be less flexible from the stand)Xlint of
multiple administration sets, than is now seen, but the decision must be made.
Is contamination of intravenous fluids the price to pay for the flexibility of
numerous different administration sets?
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TABLE I
Number of Positive Cultures a nd Microorganisms Isolated
from Individual Components - Bickground Data

Number of
Components

Component
Cultured

Fluid in Flexible
Plastic Bags
Fluid in Gl ass
Bottles
Infusion Sets
Final In-line
Filters

Blood Agar Settling
Plates in Lamin3.r
Air Flow Hood

Number of
Positive Cultures

50

I

50

I

Species of
Organism Isolated

None Isolated

1 (2%)

Penicillium species

54

2 (3. 7%)

Staphylococcus e pidermidis
Flavobacterium species

16

4 (25%)

Bacillus species,
Penicillium s pecies,
Aspergillus species,
Mycelium sterilia,
Staphylococcus epidermidiE

40

None Isolated

~
~

TABLE 2
Number of Positive Cultures and Microorganisms Isolated
from Units Assembled by Nurses
on a Patient Care Unit - Glass Bottles

Nurse

Number of
Units Prepared

A

19

B

18

c

18

Number of
Positive Cultures

Species of
Organism Isolated

None Isolated
None Isolated

w

m

4 (22%)

Staphylococcus epidermidis,
Bacillus ~()t::t.: t t::~
Streptococcus species ,

9 ~OO %)

Escherichia coli

55

4 (7.1%)

Staphylococcus epidermidis,
Bacillus species,
~occus species

18

3 ~6. 7%)

Staphylococcus epidermidis,
Micrococcus species,
Bacillus species

Controls
Total Less
Controls

Blood Agar
Settling Plates
in Laminar Air
Flow Hood

TABLE 3

Number of Positive Cultures and Microorganis ms Isolated
from Units Assembled by Nurses
on a Patient Care Unit - Plastic Bags

Nurse

A

I

Number of
Units Prepared

Positive Cultures

19

3 (15. 8%)

Number of

Species of
Organism Isolated

Bacillus species,
staj?hYiOcoccus epidermidis ,
Micr ococcus species

B

18

3 ~6 . 7%)

~ s pecies ,

c

18

0

None Isolated

9

9 ~00%)

Escherichia coli

55

s n o .9%)

Bacillus s pecies,
~coccus epidermidis,
Micrococcus species

3 (16.W!;)

Staphylococcus epidermidis ,
Bacillus s pecies ,
~ccus s pecies

Micrococcus species

Controls
Total Less
Controls

Blood Agar
Settling Plates
in Laminar Air
Flow Hood

I

18

I

"'
~

TABLE 4

Number of Positive Cultures and Microorganisms
Is olated from Units Assembled by Pharmacis ts
in a Laminar Air Flow Hood - Gl ass Bottles

Number of

Pliarmacist

A

B\1

I

I

Number of

Species of
Or ganism Isolated

Units Prepared

Pos itive Cultures

23

1 (4. 3%)

St aphylococcus epide rmidis ,

32

2 (6 . 2%)

Micrococcus species ,
Bacillus species

Control s

10

10 (100%)

Es cherichia coli

Total Less

55

3 (5 . 4%)

Staphylococcus epiderm idis ,
Micr ococcus species ,
Bacillus species

20

3 (15%)

Staphylococcus epidermidis ,
Bacillus species,

Controls

Blood Agar
Settling Plates
in Laminar Air
Flow Hood

MiCroCoccus species

~

'"

TABLE 5

Number of Positive Cultures and Microorganisms
Isolated from Units Assembled by Pharmacists
in a Laminar Air Flow Hood - Plastic Bags

Number of

Pharmacist

I

'A
~'

I

Units Prepared

Number of
Positive Cultures

Species of
Organism Isolated

24

1 (4.2%)

Escherichia coli

30

2 (6. 7%)

Staphylococcus aureus,
Bacillus species

Controls

10

10 (100 %)

Escherichia coli

Total Less
Controls

54

3 (5. 5%)

Escherichia coli,
Bacillus species,
Staphylococcus aureus

Blood Agar
Settling Plates
in Laminar Air
Flow Hood

20

3 ~5%)

Staphylococcus epidermidis,
Bacillus species,
~ccus species
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TABLE 6

Statistical Analysis
Confidence Limit at 95% Interval (P=0.05)

Background

Pharmacists

Nurses

Plastic Bags

0 . 08

0 . 02-0.17

0.06-0 . 27

Glass Bottles

O.Ol-0.13

0.01-0.17

0.025-0.19
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Configuration of Complete Units as Tes ted

A.

Site for ins ertion of adminis tration set

B.

Drip chamber of admin is tration set

C.

Rolle r clamp s upplied by m anufacturer

D.

Final in - line fil ter

E.

Vacuum collect ion bottle

